Child-resistant cap may malfunction, so Novartis issues recall

Novartis Consumer Health, Inc. is voluntarily recalling certain lots of Triaminic® Syrups and Theraflu Warming Relief® Syrups that were manufactured in the United States prior to December 31, 2011.

Novartis Consumer Health has decided to issue a voluntary recall to consumers, retail customers and wholesalers in the U.S. because the child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed with the tamper-evident seal still in place.

Consumers with questions are encouraged to contact the Novartis Consumer Relationship Center at 1-866-553-6742 (available Monday-Saturday 8 a.m. to midnight Eastern Time).

According to witn.com, 2.3 million units of Traminic and Theraflu are under recall. One child has needed medical attention after getting into the package, three others took the medicine but were okay, and eight other kids opened the medicine but did not ingest it, says witn.com

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026
Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground